The Oncosearch | Oncotarget

Endometrial cancer cells exhibit high expression of p110Î² and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation Research Paper

Thomas Karlsson, Camilla Krakstad, Ingvild LÃ¸berg Tangen, Erling A. Hoivik, Pamela M. Pollock, Helga B. Salvesen, AurÃ©lia E. Lewis

Published Dec 16, 2016 · Vol. 8, No. 3 · pp. 3881-3894

Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells Research Paper

Ilaria Guerriero, Daniela D'Angelo, Pierlorenzo Pallante, Mafalda Santos, Marianna Scrima, Donatella Malanga, Carmela De Marco, Maria Ravo, Alessandro Weisz, Carmelo Laudanna, Michele Ceccarelli, Geppino Falco, Antonia Rizzuto, Giuseppe Viglietto

Published Nov 17, 2016 · Vol. 8, No. 12 · pp. 19172-19191

E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3KÎ² silencing Research Paper

Ãfrica MillÃ¡n-UclÃ©s, Susana Zuluaga, Miriam MarquÃ©s, Jesus Vallejo-DÃaz, Lorena Sanz, Ariel E. Cariaga-MartÃnez, Francisco X. Real, Ana C. Carrera

Published Nov 16, 2016 · Vol. 7, No. 51 · pp. 84054-84071

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer Research Paper

Evelyn Kidess-Sigal, Haiyan E. Liu, Melanie M. Triboulet, James Che, Vishnu C. Ramani, Brendan C. Visser, George A. Poultsides, Teri A. Longacre, Andre Marziali, Valentina Vysotskaia, Matthew Wiggin, Kyra Heirich, Violet Hanft, Ulrich Keilholz, Ingeborg Tinhofer, Jeffrey A. Norton, Mark Lee, Elodie Sollier-Christen, Stefanie S. Jeffrey

Published Nov 15, 2016 · Vol. 7, No. 51 · pp. 85349-85364

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab Clinical Research Papers

Rodrigo A. Toledo, Antonio Cubillo, Estela Vega, Elena Garralda, Rafael Alvarez, Lisardo U. de la Varga, JesÃºs R. Pascual, Gema SÃ¡nchez, Francesca Sarno, Susana H. Prieto, SofÃa Perea, Pedro P. LopÃ©z-Casas, Fernando LÃ³pez-RÃos, Manuel Hidalgo

Published Nov 11, 2016 · Vol. 8, No. 21 · pp. 35289-35300

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer Research Paper

Sandrine Tury, VÃ©ronique Becette, Franck Assayag, Sophie Vacher, Camille Benoist, Maud Kamal, Elisabetta Marangoni, Ivan BiÃ¨che, Florence Lerebours, CÃ©line Callens

Published Nov 8, 2016 · Vol. 7, No. 51 · pp. 85124-85141

Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma Research Paper

JesÃºs Vallejo-DÃaz, Manuel Olazabal-MorÃ¡n, Ariel E. Cariaga-MartÃnez, MarÃa J. Pajares, Juana M. Flores, Ruben Pio, Luis M. Montuenga, Ana Clara Carrera

Published Nov 8, 2016 · Vol. 7, No. 51 · pp. 85063-85078

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts Priority Research Paper

Lei Wei, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, May Elbanna, Jianmin Wang, Qiang Hu, Sean T. Glenn, Mitsuko Murakami, Lu Liu, Eduardo Cortes Gomez, Yuchen Sun, Jacob Conroy, Kiersten Marie Miles, Kullappan Malathi, Sudha Ramaiah, Anand Anbarasu, Anna Woloszynska-Read, Candace S. Johnson, Jeffrey Conroy, Song Liu, Carl D. Morrison, Roberto Pili

Published Nov 3, 2016 · Vol. 7, No. 47 · pp. 76374-76389

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast Research Paper

Zheng Ping, Gene P. Siegal, Shuko Harada, Isam-Eldin Eltoum, Mariam Youssef, Tiansheng Shen, Jianbo He, Yingjie Huang, Dongquan Chen, Yiping Li, Kirby I Bland, Helena R Chang, Dejun Shen

Published Nov 2, 2016 · Vol. 7, No. 49 · pp. 80655-80663

Clinical outcomes based on multigene profiling in metastatic breast cancer patients Priority Research Paper

Reva K. Basho, Debora de Melo Gagliato, Naoto T. Ueno, Chetna Wathoo, Huiqin Chen, Maryam Shariati, Caimiao Wei, Ricardo H. Alvarez, Stacy L. Moulder, Aysegul A. Sahin, Sinchita Roy-Chowdhuri, Mariana Chavez-MacGregor, Jennifer K. Litton, Vincent Valero, Raja Luthra, Jia Zeng, Kenna R. Shaw, John Mendelsohn, Gordon B. Mills, Debu Tripathy, Funda Meric-Bernstam

Published Oct 28, 2016 · Vol. 7, No. 47 · pp. 76362-76373

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer Research Paper

Yu Yao, Jinghao Liu, Lei Li, Yuan Yuan, Kejun Nan, Xin Wu, Zhenyu Zhang, Yi Wu, Xin Li, Jiaqi Zhu, Xuehong Meng, Longgang Wei, Jun Chen, Zhi Jiang

Published Oct 25, 2016 · Vol. 8, No. 2 · pp. 2130-2140

Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a caucasian family Research Paper

Simona De Summa, Michele Guida, Stefania Tommasi, Sabino Strippoli, Cristina Pellegrini, Maria Concetta Fargnoli, Brunella Pilato, Iole Natalicchio, Gabriella Guida, Rosamaria Pinto

Published Oct 20, 2016 · Vol. 8, No. 18 · pp. 29751-29759

In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC Research Paper

Susan Heavey, Sinead Cuffe, Stephen Finn, Vincent Young, Ronan Ryan, Siobhan Nicholson, Niamh Leonard, Niall McVeigh, Martin Barr, Kenneth Oâ€™Byrne, Kathy Gately

Published Oct 19, 2016 · Vol. 7, No. 48 · pp. 79526-79543

Genomic characterization of high-risk non-muscle invasive bladder cancer Research Paper

Joshua J. Meeks, Benedito A. Carneiro, Sachin G. Pai, Daniel T. Oberlin, Alfred Rademaker, Kyle Fedorchak, Sohail Balasubramanian, Julia Elvin, Nike Beaubier, Francis J. Giles

Published Oct 14, 2016 · Vol. 7, No. 46 · pp. 75176-75184

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients Research Paper

Evert van den Broek, Oscar Krijgsman, Daoud Sie, Marianne Tijssen, Sandra Mongera, Mark A. van de Wiel, Eric J. Th. Belt, Sjoerd H. den Uil, Herman Bril, Hein B.A.C. Stockmann, Bauke Ylstra, Beatriz Carvalho, Gerrit A. Meijer, Remond J.A. Fijneman

Published Oct 6, 2016 · Vol. 7, No. 45 · pp. 73876-73887

Case-specific potentiation of glioblastoma drugs by pterostilbene Research Paper

LinnÃ©a Schmidt, Sathishkumar Baskaran, Patrik Johansson, Narendra Padhan, Damian Matuszewski, Lydia C Green, Ludmila Elfineh, Shimei Wee, Maria HÃ¤ggblad, Ulf Martens, Bengt Westermark, Karin Forsberg-Nilsson, Lene Uhrbom, Lena Claesson-Welsh, Michael AndÃ¤ng, Ida-Maria Sintorn, Bo Lundgren, Ingrid LÃ¶nnstedt, Cecilia Krona, Sven Nelander

Published Sep 28, 2016 · Vol. 7, No. 45 · pp. 73200-73215

Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers Research Paper

Piera Rizzolo, Anna Sara Navazio, Valentina Silvestri, Virginia Valentini, Veronica Zelli, Ines Zanna, Giovanna Masala, Simonetta Bianchi, Marco ScarnÃ², Stefania Tommasi, Domenico Palli, Laura Ottini

Published Sep 27, 2016 · Vol. 7, No. 45 · pp. 74097-74106

Genomic characterization of liver metastases from colorectal cancer patients Research Paper

JosÃ© MarÃa SayaguÃ©s, LuÃs Antonio Corchete, MarÃa Laura GutiÃ©rrez, Maria Eugenia Sarasquete, MarÃa del Mar Abad, Oscar Bengoechea, Encarna FermiÃ±Ã¡n, MarÃa Fernanda Anduaga, Sofia del Carmen, Manuel Iglesias, Carmen Esteban, MarÃa Angoso, Jose Antonio Alcazar, Jacinto GarcÃa, Alberto Orfao, LuÃs MuÃ±oz-Bellvis

Published Sep 20, 2016 · Vol. 7, No. 45 · pp. 72908-72922

LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer Priority Research Paper

Whitney S. Henry, David G. Hendrickson, Francisco Beca, Benjamin Glass, Marianne Lindahl-Allen, Lizhi He, Zhe Ji, Kevin Struhl, Andrew H. Beck, John L. Rinn, Alex Toker

Published Sep 10, 2016 · Vol. 7, No. 50 · pp. 81981-81994

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up Research Paper

Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin, Ellen C. Zwarthoff, Paolo Vineis, Carlotta Sacerdote, Giuseppe Matullo, Alessio Naccarati

Published Sep 7, 2016 · Vol. 7, No. 41 · pp. 67435-67448

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Endometrial cancer cells exhibit high expression of p110Î² and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation Research Paper

Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells Research Paper

E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3KÎ² silencing Research Paper

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer Research Paper

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab Clinical Research Papers

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer Research Paper

Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma Research Paper

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts Priority Research Paper

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast Research Paper

Clinical outcomes based on multigene profiling in metastatic breast cancer patients Priority Research Paper

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer Research Paper

Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a caucasian family Research Paper

In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC Research Paper

Genomic characterization of high-risk non-muscle invasive bladder cancer Research Paper

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients Research Paper

Case-specific potentiation of glioblastoma drugs by pterostilbene Research Paper

Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers Research Paper

Genomic characterization of liver metastases from colorectal cancer patients Research Paper

LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer Priority Research Paper

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Endometrial cancer cells exhibit high expression of p110Î² and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation Research Paper

Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells Research Paper

E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3KÎ² silencing Research Paper

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer Research Paper

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab Clinical Research Papers

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer Research Paper

Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma Research Paper

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts Priority Research Paper

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast Research Paper

Clinical outcomes based on multigene profiling in metastatic breast cancer patients Priority Research Paper

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer Research Paper

Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a caucasian family Research Paper

In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC Research Paper

Genomic characterization of high-risk non-muscle invasive bladder cancer Research Paper

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients Research Paper

Case-specific potentiation of glioblastoma drugs by pterostilbene Research Paper

Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers Research Paper

Genomic characterization of liver metastases from colorectal cancer patients Research Paper

LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer Priority Research Paper

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up Research Paper